GWP
GILD icon

Gateway Wealth Partners’s Gilead Sciences GILD Stock Holding History

Gateway Wealth Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$923K Sell
7,305
-2,993
-29% -$394K 0.06% 321
2026
Q1 		$1.44M Buy
10,298
+6,225
+153% +$872K 0.06% 311
2025
Q4 		$500K Buy
4,073
+19
+0.5% +$2.31K 0.06% 276
2025
Q3 		$450K Sell
4,054
-155
-4% -$17.6K 0.06% 257
2025
Q2 		$467K Buy
4,209
+288
+7% +$30.6K 0.09% 206
2025
Q1 		$439K Buy
3,921
+271
+7% +$28K 0.1% 199
2024
Q4 		$337K Buy
3,650
+71
+2% +$6.39K 0.09% 215
2024
Q3 		$300K Sell
3,579
-499
-12% -$38.1K 0.08% 212
2024
Q2 		$280K Sell
4,078
-381
-9% -$25.4K 0.08% 212
2024
Q1 		$327K Buy
4,459
+1,233
+38% +$94.8K 0.12% 162
2023
Q4 		$261K Sell
3,226
-209
-6% -$16.3K 0.11% 171
2023
Q3 		$257K Buy
3,435
+399
+13% +$30.7K 0.05% 215
2023
Q2 		$234K Buy
+3,036
New +$242K 0.04% 213
2023
Q1 		– Sell
-2,476
Closed -$213K – 237
2022
Q4 		$213K Buy
+2,476
New +$196K 0.04% 185

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Gateway Wealth Partners's GILD Position: Q2 2026 in Review

Gateway Wealth Partners reduced its Gilead Sciences (GILD) stake by 29% in Q2 2026, selling an estimated $394K and leaving 7,305 shares worth $923K. The position accounts for 0.06% of the portfolio, ranked #321.

Gateway Wealth Partners first reported a position in GILD in Q4 2022 and has held it in 14 quarters since. The position peaked at $1.44M in Q1 2026. 2,279 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Gateway Wealth Partners held 7,305 shares of Gilead Sciences worth $923K as of Q2 2026.
  • Gateway Wealth Partners sold 2,993 Gilead Sciences shares in Q2 2026, an estimated $394K.
  • Gilead Sciences made up 0.06% of Gateway Wealth Partners's portfolio in Q2 2026, its #321 holding.
  • Gateway Wealth Partners first reported a position in Gilead Sciences in Q4 2022 and has held it in 14 quarters since.
  • Gateway Wealth Partners's Gilead Sciences position peaked at $1.44M in Q1 2026.
  • 2,279 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Gateway Wealth Partners's 13F filing for Q2 2026, filed 4 Aug 2026.